GlassScriptPhysician profile
Shiv Bagga
NPI 1184972531
$45,156.30
in general payments reported to CMS, 2019-2025
22 companies · $3,488 in 2025
The $3,488 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $239 · 2021: $978 · 2022: $32K · 2023: $5,054 · 2024: $3,197 · 2025: $3,488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,973 · Food and Beverage: $3,766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,973.31 |
| Food and Beverage | $3,766.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16,311.69 | 2022-2024 | Corevalve Evolut R |
| Boston Scientific Corporation | $15,343.61 | 2021-2023 | Watchman Access System |
| Abbott Laboratories | $7,075.51 | 2020-2025 | Amplatzer Amulet, Mitraclip, Amplatzer |
| Penumbra, INC. | $1,698.60 | 2024 | Indigo System, Penumbra System |
| Edwards Lifesciences Corporation | $1,256.56 | 2023-2025 | Pascal |
| Philips North America LLC | $941.64 | 2022-2023 | |
| Siemens Medical Solutions USA, INC. | $477.93 | 2025 | |
| Amgen INC. | $441.58 | 2021-2022 | |
| Biotronik INC. | $354.98 | 2021-2022 | |
| Abiomed | $293.20 | 2023-2025 | Impella |
| Thrombolex, INC. | $177.56 | 2024 | Bashir Endovascular Catheter |
| Novartis Pharmaceuticals Corporation | $155.97 | 2024-2025 | |
| Heartflow, INC. | $112.96 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $110.25 | 2024-2025 | Assure Wcd |
| Cardiac Dimensions, INC. | $96.68 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $94.74 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $91.49 | 2023-2025 | Lifevest |
| Biosense Webster, INC. | $42.49 | 2025 | Nuvision Ice Catheter |
| Terumo Medical Corporation | $30.72 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.81 | 2025 | Jardiance |
| Zoll Respicardia, INC. | $16.20 | 2025 | Remede System |
| E.R. Squibb & Sons, L.L.C. | $15.13 | 2025 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shiv Bagga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.